The mastermind locus encodes a nuclear protein required in the Notch signalling pathway. In a screen for genes affecting wing pattern, we identified an EP element that directs expression of an alternatively spliced form of the mastermind transcript that we call mam [DN]. 
Introduction
mastermind was identified as a neurogenic gene on the basis of its embryonic lethal phenotype; an excess of neuronal cells at the expense of epidermal cells (Lehmann et al., 1983) . This defect is similar to that produced by Notch mutants, and led to the idea that mastermind might be involved in Notch signalling. Notch signalling depends on an ordered series of proteolytic cleavage events. Ligandinduced cleavage of the extracellular domain permits Nicastrin and presenilin-dependent cleavage of the transmembrane domain thereby releasing the intracellular domain of the receptor (reviewed by Fortini, 2001; Chung and Struhl, 2001; Goutte et al., 2002; Hu et al., 2002; Kopan and Goate, 2002; Lopez-Schier and St. Johnston, 2002) . Following cleavage, the intracellular domain, Notch(intra), translocates to the nucleus with a CSL-family DNA-binding protein and activates transcription of target genes (Fortini and Artavanis-Tsakonas, 1994; Gho et al., 1996; Jarriault et al., 1995; Lecourtois and Schweisguth, 1995; Neumann and Cohen, 1996) . Notch(intra) has constitutive, ligand-independent signalling activity (Lieber et al., 1993; Rebay et al., 1993; Struhl et al., 1993) . Experiments using Notch(intra) fused to the DNA-binding domains of Gal4 or LexA have shown that Notch is capable of providing activation functions when tethered to DNA (Lecourtois and Schweisguth, 1998; Struhl and Adachi, 1998) .
Experiments using Notch(intra) have suggested that mastermind activity is required for activation of target genes (Schuldt and Brand, 1999) . Proteins with similarity to Mam have been described in Caenorhabditis elegans (Lag-3) and man (MAML1) (Petcherski and Kimble, 2000; Wu et al., 2000) . The N-terminus of Mam, Lag-3 and MAML1 interact with the DNA-binding proteins Su(H), CBF, RBP-Jk in the presence of the intracellular fragment of Notch (Petcherski and Kimble, 2000; Wu et al., 2000) . Together, MamL1, Notch(intra) and CSL can stimulate transcription of a vertebrate Notch target gene, Hes1. In addition, a fusion of the C. elegans Lag-3 protein with the DNA-binding protein LexA behaves as a potent transcriptional activator in yeast (Petcherski and Kimble, 2000) . These findings suggest that Mam acts as a co-activator for transcription of Notch-dependent target genes by forming a ternary complex with Notch and a DNA-binding protein of the Su(H)/CBF/RBP-Jk family. Expression of a truncated form of Mam in vivo has been reported to interfere with notch activity (Helms et al., 1999 Using the modular misexpression system described by Rorth (1996) and Mata et al. (2000) , we performed a screen for genes affecting wing development and identified an EPg insertion at the mastermind locus. EPgJ3-285 caused severe scalloping of the wing when expressed under control of omb Gal4 (Fig. 1A, B) . Scalloping can reflect loss of Notch activity (de Celis and Garcia Bellido, 1994) or loss of Wg activity (Diaz-Benjumea and Cohen, 1995) . To distinguish between these possibilities we examined the phenotypes produced when J3-285 was expressed in dorsal cells under ap Gal4 control. J3-285 expression caused thickening of the dorsal veins 3 and 5 (Fig. 1C ). This suggested that the transcript expressed by EPg J3-285 reduced Notch function during wing development (see de Celis et al., 1997) .
The EPg element J3-285 was inserted in the third intron of the mastermind locus ( Fig. 1D ; Myers et al., 2000; Smoller et al., 1990) . The insertion site corresponded to the 5 0 UTR of a naturally occurring transcript identified by EST GH07841. We performed in situ hybridisation with probes specific for GH07841 (not overlapping the conventional mam transcript; Fig. 1D probe S) to verify that this transcript was overexpressed by the EP line (not shown). Expression of GH07841 under Gal4 control produced the same phenotype as EPg J3-285, confirming that this transcript encodes the activity identified by the EPg element (not shown). The GH07841 transcript shares one exon with the conventional mastermind transcript. GH07841 has two short exons before the shared exon and one short exon after it. The predicted open reading frame of GH07841 begins in its second exon, which encodes only four amino acids, continues through the common exon in the same reading frame as Mam and ends after an additional four amino acids encoded by its fourth exon. Thus, the alternate transcript is predicted to produce a short form of the Mam protein that differs at both the N-and C-termini, but which is identical to the conventional Mam protein through the shared exon. The alternate form of Mam protein encoded by GH07841 would lack the conserved N-terminal domain that is needed for interaction with the Ankyrin repeats of Notch and Su(H) (Petcherski and Kimble, 2000; Wu et al., 2000) .
The phenotypes produced by expression of GH07841 in the wing suggest that the Mam[DN] protein interferes with Notch signalling activity. During embryonic development Notch activity is needed to instruct cells in the neurectoderm to undergo epidermal differentiation. When Notch activity is reduced too many cells adopt neuronal fate and too few adopt epidermal identity. Excess Notch activity generated by expression of the activated form of Notch under arm Gal4 control caused loss of neurons in the peripheral and central nervous systems ( Fig. 2A, B ; as described previously by Struhl et al., 1993) . Overexpression of the conventional form of Mam also reduced the number of PNS neurons and caused some variable loss in the CNS (Fig. 2C) , suggesting an increase in Notch signalling activity. Conversely, expression of Mam[DN] under arm Gal4 control increased the number of PNS neurons (Fig. 2D, arrows) and caused expansion of the CNS. Excess production of neurons resembles the defects in embryos mutant for mastermind or Notch. Thus, overexpression of Mam [DN] reduces Notch activity. Its activity is opposite to that of the conventional form of the locus. (Fig.  3A) . Conversely, clones of cells expressing Notch(intra) induced ectopic expression of Wg (Fig. 3B) . Co-expression of Mam [DN] with Notch(intra) suppressed ectopic Wg expression (Fig. 3C) . However, co-expression of Mam [DN] did not block the ability of an activated form of Su(H) to induce Wg expression (Fig. 3D) this case VP16 (Kidd et al., 1998) . This suggests a role for Mastermind together with Notch(intra) in the displacement of the repression machinery that is recruited by Su(H) in the absence of signalling (Furriols and Bray, 2000; Furriols and Bray, 2001; Morel et al., 2001; Morel and Schweisguth, 2000) . When co-expressed with conventional Mam, Mam [DN] was not able to block wingless expression, suggesting that Mam[DN] competes with Mam activity for the binding to a cellular factor necessary to activate Notch target genes (not shown).
mam[DN] is expressed in a subset of cells in the embryonic CNS and in the eye imaginal disc
The conventional form of Mam is ubiquitously expressed in the embryo and in the imaginal discs (Schmid et al., 1996) . To analyse the pattern of expression of mam [DN] we used the exon-specific RNA probe 'S' (Fig. 1D) . mam [DN] was first detected by in situ hybridisation in two pairs of cells adjacent to the midline in each segment at stage 10-11 (Fig. 4A ). These cells were the first to be labelled with Mab22C10 (Fig. 4B, C) , suggesting that they are vMP2 and dMP2 (Schuldt and Brand, 1999) . Later, expression of mam[DN] concentrated in vMP2 (Fig. 4D-I ). Between stages 13 and 15 mam[DN] accumulated in the CNS and in the salivary glands ( Fig. 4G-J (Helms et al., 1999) .
Materials and methods

In situ hybridisation
A 189 bp EcoRI-XhoI fragment corresponding to exons 1 and 2 of EST GH07841 was cloned into pBluescript KS and used as a template to synthesise sense and anti-sense DIGlabelled RNA probes (according to manufacturer's instructions, Ambion).
Antibody staining
The ORF of Mam [DN] was cloned in pET23. The protein was expressed in bacteria and the insoluble fraction was used to immunise rats and mice. The antibody recognises both forms of Mam protein. Mouse monoclonal anti-Wingless (Brook and Cohen, 1996) and 22C10 (obtained from the Developmental Studies Hybridoma Bank at University of Iowa) were used at 1:10 dilution of tissue culture supernatants.
